Glimerit-MP 1 Tablet ER
Marketer
Dr. Ethix's Product & Services Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimerit-MP 1 Tablet ER
Glimepiride-Metformin extended-release tablets manage blood glucose levels in adults with type 2 diabetes. Used alongside diet and exercise, this combination medication enhances insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and regimen; take with food to minimize stomach discomfort. If a dose is missed, take it promptly unless nearing the next dose, then skip it. Never double the dose; overdose risks dangerously low blood sugar (hypoglycemia). Hypoglycemia can occur with concurrent antidiabetic drugs, alcohol, or missed meals; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your physician before use if you have kidney, liver, or heart issues, or are pregnant/breastfeeding. Kidney function will be assessed prior to treatment initiation. Limit alcohol consumption to lessen potential side effect risk.
Primary Ingredients of Glimerit-MP 1 Tablet ER
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glimerit-MP 1 Tablet ER
Managing type 2 diabetes
Major Benefits of Glimerit-MP 1 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. The extended-release Glimerit-MP tablet should be taken with a meal.
Common Side effects of Glimerit-MP 1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimerit-MP 1 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Glimerit-MP 1 Extended-Release Tablet with a meal.
How Glimerit-MP 1 Tablet ER works:
Glimerit-MP 1 Tablet ER combines three distinct antidiabetic agents—glimepiride, metformin, and pioglitazone—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimerit-MP 1 Tablet ER and alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimerit-MP 1 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimerit-MP tablets (1 mg) likely pose a risk during lactation. Available evidence from humans indicates potential drug transfer to breast milk, possibly causing infant harm.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Glimerit-MP 1 Tablet ER to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. For patients exhibiting severe kidney disease, Glimerit-MP 1 Tablet ER is contraindicated. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Exercise caution when prescribing Glimerit-MP 1 Tablet ER to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before administering. Glimerit-MP 1 Tablet ER is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Glimerit-MP 1 Tablet ER :
Should you forget to take a Glimerit-MP 1 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimerit-MP 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently